No data from RCT are available on the usefulness and safety of specific left-side HF therapies (β-blockers, angiotensin-converting enzyme-inhibitors, angiotensin receptor-neprilysin, sodium-glucose cotransporter-2 inhibitors) in PAH [8,82,105]. The gene discussed is ACE; the disease is hydrops fetalis.